Cheng, J <br/><br/>
A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways.  [electronic resource] 

 -  Cell death & disease  Feb 2014 
 - e1079 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-4889 
<br/><br/><label>Standard No.: </label>10.1038/cddis.2014.54  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Active Transport, Cell Nucleus--drug effects<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Neoplasm<br/>Enzyme Activation<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>HEK293 Cells<br/>Humans<br/>JNK Mitogen-Activated Protein Kinases--antagonists & inhibitors<br/>Mice<br/>Mice, Nude<br/>Mutation<br/>Neuroblastoma--drug therapy<br/>Protein Kinase Inhibitors--pharmacology<br/>Signal Transduction--drug effects<br/>Time Factors<br/>Transfection<br/>Tumor Burden--drug effects<br/>Tumor Suppressor Protein p53--genetics<br/>Ubiquitin-Conjugating Enzymes--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays